Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Jasper Therapeutics Inc (NASDAQ: JSPR) was $1.72 for the day, up 1.18% from the previous closing price of $1.7. In other words, the price has increased by $1.18 from its previous closing price. On the day, 0.62 million shares were traded. JSPR stock price reached its highest trading level at $1.825 during the session, while it also had its lowest trading level at $1.695.
Ratios:
Our analysis of JSPR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.59 and its Current Ratio is at 2.59. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 22 ’25 when WIGGANS THOMAS G bought 41,000 shares for $2.43 per share. The transaction valued at 99,630 led to the insider holds 41,000 shares of the business.
Lucas Svetlana bought 20,000 shares of JSPR for $48,600 on Sep 22 ’25. The Director now owns 20,000 shares after completing the transaction at $2.43 per share. On Sep 22 ’25, another insider, MARTELL RON, who serves as the President and CEO of the company, bought 41,000 shares for $2.43 each. As a result, the insider paid 99,630 and bolstered with 74,118 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JSPR now has a Market Capitalization of 48132548 and an Enterprise Value of -1063452.
Stock Price History:
The Beta on a monthly basis for JSPR is 3.09, which has changed by -0.9248785 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, JSPR has reached a high of $26.05, while it has fallen to a 52-week low of $1.56. The 50-Day Moving Average of the stock is -22.49%, while the 200-Day Moving Average is calculated to be -55.63%.
Shares Statistics:
JSPR traded an average of 365.22K shares per day over the past three months and 427660 shares per day over the past ten days. A total of 27.98M shares are outstanding, with a floating share count of 24.26M. Insiders hold about 13.29% of the company’s shares, while institutions hold 59.97% stake in the company. Shares short for JSPR as of 1761868800 were 1525711 with a Short Ratio of 4.18, compared to 1759190400 on 1511116. Therefore, it implies a Short% of Shares Outstanding of 1525711 and a Short% of Float of 5.5.
Earnings Estimates
The market rating of Jasper Therapeutics Inc (JSPR) is currently shaped by the ongoing analysis conducted by 3.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.68, with high estimates of -$0.56 and low estimates of -$0.79.
Analysts are recommending an EPS of between -$3.74 and -$5.67 for the fiscal current year, implying an average EPS of -$4.8. EPS for the following year is -$3.29, with 6.0 analysts recommending between -$1.34 and -$4.91.
